Two Sigma Investments’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-50,557
| Closed | -$287K | – | 4709 |
|
|
2025
Q4 | $287K | Buy |
50,557
+38,115
| +306% | +$215K | ﹤0.01% | 3596 |
|
|
2025
Q3 | $76.1K | Buy |
12,442
+1,846
| +17% | +$9.56K | ﹤0.01% | 3502 |
|
|
2025
Q2 | $33.9K | Buy |
10,596
+41
| +0.4% | +$158 | ﹤0.01% | 3092 |
|
|
2025
Q1 | $42.7K | Sell |
10,555
-1,485
| -12% | -$10.4K | ﹤0.01% | 3061 |
|
|
2024
Q4 | $128K | Sell |
12,040
-2,950
| -20% | -$52.6K | ﹤0.01% | 2940 |
|
|
2024
Q3 | $370K | Sell |
14,990
-7,952
| -35% | -$210K | ﹤0.01% | 2590 |
|
|
2024
Q2 | $647K | Sell |
22,942
-8,473
| -27% | -$275K | ﹤0.01% | 2233 |
|
|
2024
Q1 | $1.28M | Sell |
31,415
-293
| -0.9% | -$6.9K | ﹤0.01% | 1784 |
|
|
2023
Q4 | $523K | Buy |
+31,708
| New | +$553K | ﹤0.01% | 2435 |
|
|
2022
Q4 | – | Sell |
-3,157
| Closed | -$168K | – | 2901 |
|
|
2022
Q3 | $168K | Buy |
3,157
+1,957
| +163% | +$122K | ﹤0.01% | 2146 |
|
|
2022
Q2 | $79K | Sell |
1,200
-10,292
| -90% | -$673K | ﹤0.01% | 2295 |
|
|
2022
Q1 | $844K | Sell |
11,492
-12,806
| -53% | -$742K | ﹤0.01% | 1785 |
|
|
2021
Q4 | $1.72M | Buy |
+24,298
| New | +$4.24M | ﹤0.01% | 2059 |
|
Other funds holding GBIO
Two Sigma Investments's GBIO Position: Q1 2026 in Review
Two Sigma Investments sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 50,557 shares — an estimated $287K sold.
Two Sigma Investments first reported a position in GBIO in Q4 2021 and held it in 13 quarters. The position peaked at $1.72M in Q4 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Two Sigma Investments reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Two Sigma Investments sold 50,557 Generation Bio shares in Q1 2026, an estimated $287K.
- Two Sigma Investments first reported a position in Generation Bio in Q4 2021 and held it in 13 quarters.
- Two Sigma Investments's Generation Bio position peaked at $1.72M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.